Emil N.
- Country
- Sweden
- Department
- FoU Tema Hjärta Kärl, Eugeniavagen 3 Solna
Research Overview
- Phase 2b Open-Label Study Evaluating Tolerability and Safety of 5 mg Vericiguat in Chronic Heart Failure with Reduced Ejection Fraction
- A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction
Data & Insights
Has run more than one trial at 18 of 139 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating patients with chronic heart failure, with particular emphasis on cases involving reduced ejection fraction (HFrEF). Their clinical research focuses on evaluating innovative therapeutic approaches for managing cardiac conditions.
- Heart Failure Management
- Cardiovascular Risk Assessment
- Cardiac Function Optimization
Their expertise extends to investigating therapeutic interventions aimed at reducing cardiovascular mortality and preventing heart failure hospitalizations.
Clinical Therapeutics
The investigator's work centers on evaluating novel therapeutic agents for cardiovascular disease management. Their research encompasses the assessment of emerging treatments for chronic cardiac conditions.
- Drug Efficacy Evaluation
- Therapeutic Intervention Studies
- Clinical Outcomes Assessment
Their research initiatives focus on comparing therapeutic interventions against established treatment standards in cardiovascular medicine.
Preventive Cardiology
The investigator concentrates on developing strategies to prevent adverse cardiac events in patients with chronic heart conditions. Their work involves evaluating interventions that aim to reduce hospitalization rates.
- Risk Stratification
- Prevention Strategies
- Patient Outcome Optimization
Their research encompasses the development of approaches to improve long-term outcomes in patients with cardiac dysfunction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.